International practice patterns and perspectives on endovascular therapy for the treatment of cerebral venous thrombosis.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Brakel Benjamin A, Rebchuk Alexander D, Ospel Johanna, Chen Yimin, Heran Manraj Ks, Goyal Mayank, Hill Michael D, Miao Zhongrong, Huo Xiaochuan, Sacco Simona, Yaghi Shadi, Mai Ton Duy, Thomalla Götz, Boulouis Grégoire, Yamagami Hiroshi, Hu Wei, Nagel Simon, Puetz Volker, Kristoffersen Espen Saxhaug, Demeestere Jelle, Qiu Zhongming, Abdalkader Mohamad, Al Kasab Sami, Siegler James E, Strbian Daniel, Fischer Urs, Coutinho Jonathan, Munckhof Anita, Aguiar de Sousa Diana, Campbell Bruce Cv, Raymond Jean, Ji Xunming, Saposnik Gustavo, Nguyen Thanh N, Field Thalia S
Аннотация
AIMS: Here, we present a comprehensive, international characterization of practice patterns and perspectives on the use of EVT for CVT.
METHODS: A comprehensive 42-question survey was distributed to stroke clinicians globally from May to October 2023, asking about practice patterns and perspectives on the use of EVT for CVT.
RESULTS: The overall response rate was 31% (863 respondents of 2744 invited) across 61 countries. The majority of respondents (74%) supported the use of EVT for CVT in certain clinical situations. Key considerations for decision-making in using EVT favored clinical over radiographic/procedural factors and included worsening level of consciousness (86%) and worsening neurological deficits (76%). In the past 3 years, 56% of respondents used EVT for the treatment of CVT, with most (49.5%) involved in two to five cases. Among interventionalists, significant variability existed in the techniques used for EVT (p < 0.001), with aspiration thrombectomy (56%) and stent retriever (51%) being the most used overall. Regionally, interventionalists from China predominantly used intra-sinus heparin (56%), while this technique was most commonly ranked as "never indicated" throughout the rest of the world (23%). Post-procedure, low molecular weight heparin was the most used anticoagulant (83%), although North American respondents favored unfractionated heparin (37%), while imaging was primarily split between magnetic resonance (71.8%) and computed tomography (65.9%) arteriography or venography.
CONCLUSION: Our survey reveals significant heterogeneity in approaches to EVT for CVT, and provides a comprehensive characterization of indications, techniques, and long-term management used by clinicians internationally. This resource will aid in optimizing patient selection and endovascular treatments for future trials.